CSIMarket Company Name, Ticker, Competitors, else..
 
Fulgent Genetics Inc   (NASDAQ: FLGT)
Other Ticker:  
 
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Fulgent Genetics Inc Growth Comparisons

Select each growth Category to receive further Information



FLGT Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) -15.59 % 6.57 % 7.33 % 4 %
Q / Q Revenue Growth (Q3 MRQ) 0.4 % 2 % 2.74 % 0.39 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) -3.17 % 38.71 % 5.63 % %
Seq. Revenue Growth (for 12 months ending Q3 TTM) -4.52 % 1.6 % 1.78 % 1.12 %
Revenue 5 Year Average Growth 68.32 % 10.51 % 8.02 % 7.61 %


FLGT's Growth Comparisons in III. Quarter 2024




Fulgent Genetics Inc 's sharp decrease of -15.59% in sales in the third quarter from the same quarter a year ago, those results deviated strongly from rising Revenue in Medical Laboratories industry with 6.57%, and underperformed the 7.33% Revenue growth in the Healthcare sector. Although both Medical Laboratories industry and Healthcare sector posted higher gains than 4% overall market increase, Fulgent Genetics Inc was trailing overall market in the third quarter.

Comparing the company's Revenue to the second quarter results, sales were higher by 0.4% . On the yearly basis, average annual sales growth for Fulgent Genetics Inc is 68.32%, while S & P 500's including only Businesses with the third quarter 2024 earnings, average annual sales growth is 7.61% over the past five years.

FLGT Growth Rates by Company's Segments

Segment Name
Y / Y
Seq.
Laboratory Services
-15.28 %
1.01 %
Laboratory Services Precision Diagnostics
18.78 %
1.02 %
Laboratory Services Anatomic Pathology
-1.35 %
3.4 %
Laboratory Services BioPharma Services
-12.52 %
8.89 %
United States
-16.8 %
2.35 %
China
-18.76 %
12.43 %
Other countries
42.45 %
-25.29 %
Foreign
5.72 %
-11.62 %
Total
-15.59 %
0.4 %


Growth Rates of FLGT's Income in the third quarter 2024


FLGT Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) - 4.53 % 79.67 % 4.45 %
Seq. Operating Income Change (Q3 MRQ) - 53.23 % 32.65 % -2.32 %
Y / Y Operating Income Growth (Q3 TTM) - 73.44 % -6.23 % 9.3 %
Seq. Operating Income Growth (Q3 TTM) - 1.84 % 19.49 % 1.41 %
Operating Income 5 Year Avg. Change - 3.56 % 6.12 % 9.13 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) - 5.49 % 297.79 % -1.43 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) - 83.6 % 118.23 % -8.76 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) - 93.32 % 24.99 % 8.89 %
Seq. Income from Cont. Ops. Change (Q3 TTM) - 2.1 % 55.93 % -0.02 %
Income from Cont. Ops. 5 Year Avg. Change - 1.43 % -9.72 % 7.31 %

FLGT Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) - 4.97 % 7.75 % -6.22 %
Q / Q Net Income Growth (Q3 MRQ) - 95.24 % 131.96 % -6.76 %
Y / Y Net Income Change (Q3 TTM) - 85.55 % -11.95 % 5.26 %
Seq. Net Income Change (Q3 TTM) - 1.96 % 1.81 % -1.37 %
Net Income 5 Year Avg. Growth - 1.41 % -3.38 % 7.45 %

FLGT's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) - 0.02 % 297.79 % -1.43 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) - 82.4 % 118.23 % -8.76 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) - - - -6.57 %
EPS from Cont. Ops. 5 Year Avg. Growth - -8.96 % -9.72 % 7.31 %



FLGT EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) - -0.47 % 7.75 % -6.22 %
Q / Q EPS Net Growth (Q3 MRQ) - 93.97 % 131.96 % -6.76 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 44.84 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) - - - -6.16 %
EPS Net 5 Year Avg. Change - 1.41 % -3.38 % 7.45 %



Fulgent Genetics Inc reported bottom-line of $ -0.48 in the third quarter, compare to $ -0.44 in the same quarter a year ago. Medical Laboratories industry fell by -0.47%, while Healthcare sector increased by 7.75%, and overall market declined by -6.22%.

Comparing company's EPS to the second quarter results, income per share were higher by 0.4% . On the yearly basis, average annual income per share growth for Fulgent Genetics Inc is 68.32%, while S & P 500's including only the businesses with the third quarter 2024 Results, average annual income per share growth is 7.45% over the past five years.

FLGT Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - 421.4 % 38.09 % -42.75 %
Seq. Free Cash Flow Change (Q3 MRQ) - 124.86 % 108.45 % -36.75 %
Y / Y Free Cash Flow Change (Q3 TTM) -75.76 % 76.85 % 4.69 % 3.44 %
Seq. Free Cash Flow Change (Q3 TTM) -70.11 % 33.07 % 8.11 % -10.82 %
Free Cash Flow 5 Year Avg. Change - 21.91 % 7 % 11.94 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - 73.08 % -74.08 % -
Seq. Net Cash Flow Change (Q3 MRQ) - - - -
Y / Y Net Cash Flow Change (Q3 TTM) - 41.49 % - -
Seq. Net Cash Flow Change (Q3 TTM) - 101.49 % - -
Net Cash Flow 5 Year Avg. Change 135.89 % 17.74 % 11.17 % -33.53 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) 296.85 % 32.8 % 1.43 % 2.78 %
Seq. Capital Expenditures Change (Q3 MRQ) 50.93 % 1.72 % 5.75 % 2.91 %
Y / Y Capital Expenditures Change (Q3 TTM) 66.41 % 32.48 % 3.08 % 70.28 %
Seq. Capital Expenditures Change (Q3 TTM) 58.39 % 26.49 % 2.03 % -0.52 %
Capital Expenditures 5 Year Avg. Change 57.08 % 5.86 % 9.35 % 8.99 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com